page

imikhiqizo

I-YK-11 SARMs Izithasiselo Zokwakha Umzimba Zokuthola Imisipha Esheshayo Yabantu Abadala Cas 431579-34-9

Incazelo emfushane:


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Imininingwane Esheshayo

Igama Lomkhiqizo

YK11

Igama elifanayo

(17-alpha,20E)17,20-[(1-methoxyethylidene)bis(oxy)] 3-oxo-19-norpregna-4,20-diene 21-carboxylic acid methyl ester

CASE

431579-34-9

Isivivinyo

99%

Ukubukeka

Impushana emhlophe ecwebezelayo

Ukupakisha

1kg inethi/isikhwama se-foil, 5kg/isigubhu.

Okujwayelekile

I-Enterprise Standard

Isitoreji

Ukufiphaza, Ukulondolozwa Okuvalekile

Ukusetshenziswa

Ukulahlekelwa amafutha;ukukhula kwemisipha

I-Molecular Formula

I-C152H252N44O42

Isisindo samangqamuzana

3,367.2

Izinzuzo ze-YK-11

1. Usayizi omncane uyazuza ngaphandle kokugcinwa kwamanzi

2. Ukwanda kobukhulu bemisipha namandla

3. Ukuqina kwemisipha

4. Ukwenyuka kwamazinga e-Follistatin

5. Ukuvinjelwa kwamazinga e-Myostatin

6. Ngokunokwenzeka ikuvumela ukuba udlule kude izakhi zofuzo zomzimba wakho mayelana nokunqwabelana kwemisipha

7. Ikhiqiza imisipha ngendlela ehluke ngokuphelele kunama-SARM, ama-Steroids, noma i-HGH, ngakho-ke ingakwazi ukwengezwa kunoma yimuphi umjikelezo wokukhula kwemisipha eyengeziwe kanye nokuhambisana.

8. Ukwanda kokugcwala kwemisipha kanye namaphampu angcono

I-YK-11 Isikali

Ukuthatha umthamo omaphakathi (4mg - 8mg ngosuku, ama-capsules angu-2 kuya kwangu-4 ngosuku) we-"YK-11" umsebenzisi angalindela ukuthola i-Aesthetic Physique eyengeziwe (I-Lean, Hard and Strong).

Ukuthatha umthamo Omkhulu (18mg - 22mg ngosuku, ama-capsules angu-9 kuya kwangu-11) we-"YK-11" umsebenzisi uzothola Ukuthola Izicubu Zemisipha Engeziwe kanye nokugcina Ukugcwala Okugcwele Kwemisipha (Ukubukeka "Okuphunyiwe") 24/7.

Lokhu kubangelwa amakhono "YK-11" okwenza amangqamuzana emisipha akhiqize i-Follistatin eyengeziwe (ngisho nangaphezu kwe-DHT Steroids), esiza ukuvimbela ukukhiqizwa kwe-Myostatin (i-Myostatin - ikhawulela ukukhula kwemisipha).Le SARM inamandla okuba yinhle njenge-Testosterone ngesikhathi Sokuqinisa Imisipha, kodwa ngaphandle kwemiphumela emibi emibi.

Ucwaningo Lokuqala olwenziwe Umcwaningi waseJapane, u-Yuichiro Kanno, ku-2011 e-Toho University, lubonise ukuthi "i-YK-11" inamathela ku-androgen receptor futhi yenza amangqamuzana emisipha akhiqize izici eziningi ze-anabolic.Uphinde wathola ukuthi "i-YK-11" yenza amangqamuzana emisipha akhiqize i-Follistatin eyengeziwe, enciphisa i-Myostatin futhi ikhulise Ukukhula Kwemisipha.

I-YK-11 COA

PRODUCT NAME YK11
Inombolo ye-CAS. 1370003-76-1 Ubuningi 18.5kg
Isitoreji Esitsheni esingangeni moya, sivikelwe ekukhanyeni.
Izinto zokuhlaziya Ukucaciswa Imiphumela
Incazelo Impushana emhlophe ukuya kokumhlophe Iyahambisana
1HNMR Ihambisana nesakhiwo Iyahambisana
Insalela ekushiseni ≤0.5% 0.08
Ukulahlekelwa ekomisweni ≤2.0% 0.72
Isivivinyo ≥99.0% 99.62

Imikhiqizo Ehlobene

Igama

CHA.

Ukusetshenziswa

I-RAD140

1182367-47-0

Isizukulwane esisha sokuthola inqwaba nemiphetho ehlabayo

I-Andarine (S4)

401900-40-0

i-agonist ngokwengxenye, ehloselwe ikakhulukazi ukwelashwa kwe-benign prostatic hypertrophy

I-MK-677

15972-10-0

I-secretagogue ye-hormone yokukhula, ukwelashwa kokukhuluphala,

ukwelapha okuthembisayo kokwelapha ubuthakathaka kubantu asebekhulile

I-LGD-4033

1165910-22-4

iphrofayili yezemithi efana neye-enobosarm, i-Ostarine, i-MK-2866

GW1516

317318-70-0

Ngokukhuluphala, isifo sikashukela, i-dyslipidemia nesifo senhliziyo

MK2866

841205-47-8

incwadi yezokwelapha yokuvimbela i-cachexia, i-atrophy,

kanye ne-sarcopenia kanye ne-Hormone noma i-Testoserone Replacement Therapy.

I-SR9009

1379686-30-2

ngaphansi kokuthuthukiswa e-The Scripps Research Institute (TSRI),

kwandisa izinga lomsebenzi we-metabolic emisipha yamathambo amagundane

Lapha

2627-69-2

isebenza ngokufaka amachibi e-nucleoside,

akhuphuka kakhulu amazinga e-adenosine phakathi nezikhathi zokuwohloka kwe-ATP

YK11

431579-34-9

I-YK11: i-SARM ne-myostatin inhibitor endaweni eyodwa


  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona